Gynécologie-obstétrique - Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021 [Pregnancy and COVID-19: drugs and vaccine guidelines in 2021]
Fiche du document
2 février 2022
- doi: 10.53738/REVMED.2022.18.767.165
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.767.165
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35107890
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_1E848B3076C93
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Citer ce document
K. Lepigeon et al., « Gynécologie-obstétrique - Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021 [Pregnancy and COVID-19: drugs and vaccine guidelines in 2021] », Serveur académique Lausannois, ID : 10.53738/REVMED.2022.18.767.165
Métriques
Partage / Export
Résumé
During this global health crisis, COVID-19 unfortunately did not spare pregnant women, who are at greater risk of becoming infected, developing severe forms and having obstetric complications. In this article we will talk about the risks associated with COVID-19 during pregnancy and in particular the existing data on the drugs to be administered in the event of illness and how to avoid infection and its complications through vaccination.